Marianne P. Allen

Array ( [id] => 8094095 [patent_doc_number] => 20120082644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'CYTOKINES AND NEUROANTIGENS FOR TREATMENT OF IMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/262039 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21463 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082644.pdf [firstpage_image] =>[orig_patent_app_number] => 13262039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6465176 [patent_doc_number] => 20100190709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Angiogenic composition' [patent_app_type] => utility [patent_app_number] => 12/659891 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6452 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190709.pdf [firstpage_image] =>[orig_patent_app_number] => 12659891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351212 [patent_doc_number] => 20100331251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1' [patent_app_type] => utility [patent_app_number] => 12/730034 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38477 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331251.pdf [firstpage_image] =>[orig_patent_app_number] => 12730034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807167 [patent_doc_number] => 20120058120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'Targets for Growth Factor Signalling and Methods of Therapy' [patent_app_type] => utility [patent_app_number] => 13/257470 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14743 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058120.pdf [firstpage_image] =>[orig_patent_app_number] => 13257470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464639 [patent_doc_number] => 20120269807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF lgG-DECOY RECEPTOR FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/141682 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25250 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6559169 [patent_doc_number] => 20100233727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'MARKER FOR ARRHYTHMIA RISK' [patent_app_type] => utility [patent_app_number] => 12/725590 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6900 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233727.pdf [firstpage_image] =>[orig_patent_app_number] => 12725590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8759831 [patent_doc_number] => 08420350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Glycosylation-deficient hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 12/722823 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9857 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12722823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340773 [patent_doc_number] => 20100247651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'PLATELET-DERIVED GROWTH FACTOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OSTEOCHONDRAL DEFECTS' [patent_app_type] => utility [patent_app_number] => 12/718942 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 30739 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247651.pdf [firstpage_image] =>[orig_patent_app_number] => 12718942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312615 [patent_doc_number] => 20120189641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'COMBINATION ANTI-CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/203254 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30141 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515972 [patent_doc_number] => 20100211181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'NASAL PASSAGE STENT' [patent_app_type] => utility [patent_app_number] => 12/710466 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2726 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20100211181.pdf [firstpage_image] =>[orig_patent_app_number] => 12710466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545927 [patent_doc_number] => 20100222280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'PEPTIDES WITH THE CAPACITY TO BIND TO TRANSFORMING GROWTH FACTOR beta 1 (TGF-beta 1)' [patent_app_type] => utility [patent_app_number] => 12/709895 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19724 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222280.pdf [firstpage_image] =>[orig_patent_app_number] => 12709895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8059759 [patent_doc_number] => 20120079614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'CD109 POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF SKIN CELLS' [patent_app_type] => utility [patent_app_number] => 13/148273 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22460 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20120079614.pdf [firstpage_image] =>[orig_patent_app_number] => 13148273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413628 [patent_doc_number] => 08697664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Targeted binding agents directed to PDGRF-alpha and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/708022 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 154469 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348938 [patent_doc_number] => 20100248987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Screening Assay for Inhibitors of TRPA1 Activation by a Lower Alkyl Phenol' [patent_app_type] => utility [patent_app_number] => 12/700263 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12996 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20100248987.pdf [firstpage_image] =>[orig_patent_app_number] => 12700263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519757 [patent_doc_number] => 20100203087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'CHEMOREPULSION OF CELLS' [patent_app_type] => utility [patent_app_number] => 12/698732 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14387 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203087.pdf [firstpage_image] =>[orig_patent_app_number] => 12698732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236231 [patent_doc_number] => 20100267619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Methods and Compositions for Treatment of Atherosclerosis' [patent_app_type] => utility [patent_app_number] => 12/697014 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19231 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267619.pdf [firstpage_image] =>[orig_patent_app_number] => 12697014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248763 [patent_doc_number] => 20100137217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'FIBROSIS INHIBITOR FOR IMPLANTED ORGAN' [patent_app_type] => utility [patent_app_number] => 12/695532 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8582 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137217.pdf [firstpage_image] =>[orig_patent_app_number] => 12695532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574194 [patent_doc_number] => 20100129332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS' [patent_app_type] => utility [patent_app_number] => 12/693968 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23461 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129332.pdf [firstpage_image] =>[orig_patent_app_number] => 12693968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488422 [patent_doc_number] => 20110251374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'ANTIBODY PURIFICATION METHOD' [patent_app_type] => utility [patent_app_number] => 13/140601 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7956 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251374.pdf [firstpage_image] =>[orig_patent_app_number] => 13140601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8542873 [patent_doc_number] => 08318159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Anti-IGF antibodies' [patent_app_type] => utility [patent_app_number] => 12/636195 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 18488 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12636195 [rel_patent_id] =>[rel_patent_doc_number] =>)